Atopic dermatitis, or eczema, is a chronic skin condition affecting many children.
Crisaborole is a non-steroid topical medication which is FDA approved for children aged 2 and
older for eczema. This research study seeks to investigate whether crisaborole reduces
topical steroid use in children with atopic dermatitis.